Do International Cannabis Companies Deserve More Attention?


Ryan Allway

March 2nd, 2021

App, Exclusive, News, Top Story


Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market in terms of sheer size, and the Canadian national recreational program and export opportunities have captured investor attention. 

Interestingly, there are some U.S. and Canadian companies that are focused on opportunities they see in the emerging markets outside of North America. For example, the European Union medical cannabis market could be worth $64 billion by 2028. Yet, in many cases, these companies are undervalued as overseas operations are largely ignored by investors. 

Let’s take a look at three international cannabis opportunities that investors may want to consider as they diversify their portfolios.

#1. Aphria is a Dominant Force in Germany

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) recently merged with Tilray Inc. (NASDAQ: TLRY) to consolidate operations and compete effectively against larger Canadian companies. The new company expects to compete in the European market and has focused operations on the German market. 

#2. Isracann Builds Its Footprint in Israel

Isracann Biosciences Inc. (CSE: IPOT) is an Israel-based company that aims to become a low-cost producer of high-quality cannabis via its Hefer Valley-based Ein Hahoresh Farm. The company expects to serve the domestic Israeli market, and export cannabis once permitted by Israeli law. 

#3. Kaya Holdings Takes Successful Model Global

Kaya Holdings Inc. (OTCQB: KAYS) a veteran of the U.S. cannabis business, having launched Oregon operations in 2014, has decided to focus its growth on overseas markets as it waits for the U.S. market to become less fragmented, more competitive, and with less regulatory barriers. 

Taking their seven years of operational experience, their compelling brands, and their cultivation SOPs, management embarked on a mission to identify and secure viable and practical joint ventures overseas. 

To this end, the company acquired a 50% stake in Greece-based Greekkannabis PC (GKC) in January 2021. After receiving its Cannabis Installation License last year, GKC aims to build a 470,000 sq. ft. medical cannabis cultivation and processing facility on 15 acres of land in Thebes, Greece that will have an estimated production capacity of 225,000 pounds of cannabis per year.

In addition to its project in Greece, KAYS has been developing Kaya Shalva, a  project that aims to develop a 25-acre plot in Yerucham, Israel to cultivate medical cannabis. 

With these two projects, KAYS has the potential to become a key player in the global cannabis sector, able to return to the U.S. market with strength once the U.S. opportunity is ripe. Until then KAYS’ management has expressed plans to keep scouting and vetting international opportunities with an aim to continue to expand its global footprint.  

Click here to download an investor presentation and receive corporate updates

Diversifying Your Portfolio

Despite the promise of the international market, KAYS and other companies have not been granted the value consideration that often gets awarded to companies with such potential. 

Cannabis investors may want to consider diversifying their portfolio to include companies engaging the international cannabis markets. Aphria Inc. (NASDAQ: APHA), Isracann Biosciences Inc. (CSE: IPOT), and Kaya Holdings Inc. (OTCQB: KAYS) offer opportunities to do so, although it’s worth noting that KAYS’ strategy of multiple target markets provides the greater diversification opportunity.

Click here to download an investor presentation and receive corporate updates

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading